Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of a Novel Neonatal Temperature Monitor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03866122
Recruitment Status : Recruiting
First Posted : March 7, 2019
Last Update Posted : September 10, 2021
University of Malawi College of Medicine
Information provided by (Responsible Party):
William Marsh Rice University

Brief Summary:
A team of researchers at Rice University and Queen Elizabeth Central Hospital (QECH) are working to develop a low-cost temperature sensor that can continuously monitor an infant's temperature (NTM). This robust, low-cost device will allow for the individualized monitoring of each infant with alerts for hypo and hyperthermia. A reusable band placed around the infant's abdomen to hold the temperature sensor will eliminate disposable components. This study will assess the accuracy of this novel device against a gold standard (Philips Intellivue patient monitor) and up to two existing devices (Bempu and Thermospot).

Condition or disease Intervention/treatment Phase
Neonatal Hypothermia Device: NTM Monitoring Not Applicable

Detailed Description:

This study will assess the accuracy of this novel device against a commercially available patient monitor (Philips Intellivue MP30). Results will be compared to that of two existing devices designed for low resource settings: Bempu, a temperature monitor placed around an infant's wrist; and Thermospot, a sticker that changes color with temperature.

This study will enroll up to 150 infants at Queen Elizabeth Central Hospital. Up to 75 subjects will be collected from the neonatal ward and 75 subjects from the Kangaroo Mother Care (KMC) ward. This sample size will ensure that the investigators are able to collect sufficient data from infants with a range of gestational ages, weights, temperatures, and treatment locations (ie open cot, radiant warmer). The data from this study can be used to calculate the sample size needed in a larger study to evaluate changes in outcomes and nurse behavior related to the different temperature monitors (NTM, Bempu, Thermospot).

During the trial, the following steps will be taken:

A trained study nurse will assess the subject for clinical complications before attaching the temperature monitoring devices.

  1. A trained study nurse or clinician will attach the test temperature monitoring devices to the infant. A trained research assistant from Rice University or from the Biomedical Engineering Department at Malawi Polytechnic will observe all procedures and will notify the nurse of any observed errors so they may be corrected. They will also be able to answer any technical questions from the nurse. If there is any concern for the comfort or skin of the infant, only one device may be placed on at a time (NTM, Bempu, ThermoSpot).
  2. The trained study nurse will attach the temperature probe from the commercial gold standard as well as provide any other care needed.
  3. A research assistant will use a laptop to collect data from the continuous temperature monitors (NTM and gold standard). The nurse will record the temperature readings every hour from all monitors on paper forms along with the standard of care.
  4. Each time an alarm sounds from any device (Bempu and the commercial gold standard have audible alarms), the nurse will record all temperature values including a reading taken with the standard of care method. If the subject is found to be hyper/hypothermic, the nurse will respond with the appropriate standard of care.
  5. Temperature monitoring will continue for up to 3 days. The research assistant may ask the nurse to remove and reapply the temperature probes during this period.

The goal of this study is to confirm the accuracy of these temperature monitors. Target accuracy for NTM device is +/- 0.5 C. In order to confirm this temperature accuracy in the settings of both the neonatal ward and the KMC ward, 75 subjects are needed in each setting. The international standards for clinical thermometers, standard number 80601-2-56, requires that 75 subjects from each patient population be tested to demonstrate the clinical accuracy of the thermometer. The clinical accuracy is reported using a measure of bias as well as the limits of agreement.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: One or more neonatal temperature monitors will be applied to the same infant; results between the monitors will be compared.
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: Evaluating the Accuracy of a Neonatal Temperature Monitor in Comparison With Existing Temperature Monitors
Actual Study Start Date : September 6, 2017
Estimated Primary Completion Date : September 6, 2022
Estimated Study Completion Date : September 6, 2022

Arm Intervention/treatment
Experimental: Neonatal Temperature Monitor
One or more test devices (NTM, Bempu, Thermospot) will be attached to the infant in the neonatal intensive care unit (NICU) or KMC ward along with the Philips Intellivue patient monitor. Temperature will be monitored continuously using each device for up to 72 hours.
Device: NTM Monitoring
NTM and a patient monitor will continuously collect temperature for up to 72 hours. Additionally, Bempu and Thermospot may monitor temperature for up to 72 hours.

Primary Outcome Measures :
  1. Temperature measurement accuracy [ Time Frame: <72 hours ]
    Continuously measured temperature for test devices compared against Philips Intellivue patient monitor

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 28 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • The subject is currently being treated at QECH in the neonatal or KMC ward.
  • Study devices are available for use.
  • The subject's caregiver has provided informed consent for their child to participate.

Exclusion Criteria:

  • At the clinician's discretion for any reason including, but not limited to:
  • potential for skin irritation
  • Cough
  • other condition that may preclude use of the temperature belt
  • concurrent treatments that may require increased patient care

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03866122

Layout table for location contacts
Contact: Rebecca Elias, MPH 713-348-6574

Layout table for location information
United States, Texas
Rice University Recruiting
Houston, Texas, United States, 77030
Contact: Rebecca R Richards-Kortum, PhD    713-348-3823   
Contact: Z M Oden, PhD    7133484156   
Sponsors and Collaborators
William Marsh Rice University
University of Malawi College of Medicine
Layout table for investigator information
Principal Investigator: Rebecca Richards-Kortum, PhD William Marsh Rice University
Principal Investigator: Queen Dube, MD University of Malawi College of Medicine
  Study Documents (Full-Text)

Documents provided by William Marsh Rice University:
Informed Consent Form  [PDF] April 21, 2017

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: William Marsh Rice University Identifier: NCT03866122    
Other Study ID Numbers: NTM-COMREC
First Posted: March 7, 2019    Key Record Dates
Last Update Posted: September 10, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Body Temperature Changes